Innovation Pharmaceuticals Inc (IPIX)

[Stan Dango]

No human lung cell data, no human trials, just a grant application

It should be obvious by now that the ship for B for C has sailed. Now they dish out a PR saying they’re collaborating on a grant to study B as a broad spectrum antiviral. This is really the only hope for B - that it may get free money to study its application elsewhere. After all this time, and all the PR’s promising human lung cell data and to rapidly advance B into human trials, you’ve got Petri dish testing in monkey veto cells and a human kidney cell line. No lung data, no human trials. Just someone to help them fill a grant application out.

Oh, the researchers are going to publish their data after completion of in in vitro testing? No crap, that’s what researchers do. Here I’ll tell you exactly what it’ll say “While B did not show efficacy against SARS-cov-2 in human lung cells in vitro, it may potentially have applications elsewhere.” Only problem is the company is broke and “elsewhere” isn’t what the last dozen PR’s were promising.